Systemic lupus erythematosus presenting as toxic epidermal necrolysis: a case report
DOI:
https://doi.org/10.18203/2349-3291.ijcp20242747Keywords:
Epidermis, Lupus erythematosus, Cutaneous, Blister, AutoimmuneAbstract
Systemic lupus erythematosus is an autoimmune inflammatory disease with complex etiology. Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) represent a spectrum of skin lesions characterized by rashes, exfoliation, and sloughing usually following drug intake. Occasionally, TEN-like cutaneous manifestations have also been described with systemic lupus erythematosus. Recognition of lupus in a child presenting with TEN-like skin changes is clinically challenging and requires a high degree of suspicion. We present a case of a 9-year-old female with SJS/TEN like lesions following drug intake and on evaluation was found to have systemic lupus erythematosus.
References
Didier K, Bolko L, Giusti D, Toquet S, Robbins A, Antonicelli F, et al. Autoantibodies associated with connective tissue diseases: what meaning for clinicians? Front Immunol. 2018;9:541.
Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56(7):481-90.
Arringer M, Costenbader K, Daikh D. European League Against Rheumatism/American College of Rheumatology classifications criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400-12.
Sato S, Kanbe T, Tamaki Z, Furuichi M, Uejima Y, Suganuma E, Takano T, Kawano Y. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis. Pediatr Int. 2018;60(8):697-702.
Monga B, Ghosh S, Jain V. Toxic epidermal necrolysis-like rash of lupus: a dermatologist’s dilemma. Indian J Dermatol. 2014;59(4):401.
Fan WY, Zhai QR, Ma QB, Ge HX. Toxic epidermal necrolysis with systemic lupus erythematosus: case report and review of literarture. Ann Palliat Med. 2022;11(6):2144-51.
Frantz R, Huang S, Are A, Motaparthi K. Stevens-johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management. Medicina (Kaunas, Lithuania). 2021;57:9.
Tankunakorn J, Sawatwarakul S, Vachiramon V, Chanprapaph K. Stevens-johnson syndrome and toxic epidermal necrolysis-like lupus erythematosus. J CliN. Rheumatol. Practical reports on rheumatic and musculo-skeletal diseases. 2019;25(5):224-31.
Parperis K, Bhattarai B, Hadi M. Burn center admissions of patients with autoimmune rheumatic diseases: clinical characteristics and outcomes. Rheumatol Int. 2020;40:1649-56.
Zimmermann S, Sekula P, Venhoff M. Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. JAMA Dermatol. 2017;153:514-22.
Aringer M. EULAR/ACR classification criteria for SLE. Semin Arthritis Rheum. 2019;49(3):14-7.
